PubMed Health⌕ Search

Biomedical subjects

H I Morrison

Publications and source records attributed to H I Morrison.

39 records · Page 3Linked to original sources

The impending Canadian prostate cancer epidemic.

PURPOSE: To model and forecast prostate cancer incidence and mortality in Canada to the year 2016. METHODS: Bivariate multiplicative models of prostate cancer incidence and mortality for Canadian men aged 45 years or older, linear in time and Weibull in age, were fitted using weighted non-linear regression. RESULTS: The number of incident cases of prostate cancer is forecast to increase from 11,355, observed in 1990, to 26,900 by the year 2010 and to 35,200 by the year 2016. The number of deaths are estimated to climb from 3,424, observed in 1991, to an estimated 6,300 by the year 2010, and to 7,800 by the year 2016. CONCLUSIONS: The dramatic increase in prostate cancer rates with age, coupled with the expected large increase in the elderly Canadian male population and steadily increasing prostate cancer incidence rates will produce very large increases in the number of men who will have prostate cancer over the next 20 years. This has important implications for health care delivery in the future.

Age Distribution↗

Leukemia mortality and farming in the prairie provinces of Canada.

BACKGROUND: An increased risk of leukemia has been previously noted among farmers. PURPOSE: To examine the risk of fatal leukemia according to various farming practices in a large cohort of Canadian farm operators. METHODS: A cohort study of the mortality experience (1971-1987) of male farmers in Manitoba, Saskatchewan and Alberta has been conducted. The census records of 156,242 male farmers identified on the 1971 Census of Agriculture and the corresponding Census of Population were linked to mortality records through 1987. RESULTS: We observed a statistically significant test for trend (p = 0.03) between leukemia mortality and the number of chickens and/or turkeys owned (relative risk for > or = 130 chickens and/or turkeys = 1.32, 95% CI = 0.99, 1.77). No association was observed between leukemia mortality and either insecticide or herbicide use. CONCLUSIONS: Further research is necessary regarding why farmers exposed to chickens may be at an increased risk of leukemia.

Adult↗

Comparing mortality rates on CAPD/CCPD and hemodialysis. The Canadian experience: fact or fiction?

OBJECTIVE: To compare mortality rates on hemodialysis (HD) to rates on continuous ambulatory/cyclic peritoneal dialysis (CAPD/CCPD), to contrast our results with those of other recent investigations, and to discuss reasons for discrepancies. DATA SOURCES: Patient-specific data obtained from the Canadian Organ Replacement Register on patients initiating renal replacement therapy (RRT) between 1 January 1990 and 31 December 1995 (n = 14 483). Recent mortality comparisons of CAPD and HD. MAIN OUTCOME MEASURES: Mortality rate ratio (RR) based on "as-treated" (AT) analysis incorporating treatment modality switches and adjusting for age, primary renal diagnosis, and comorbid conditions using Poisson regression. Hazard ratios (HR) were estimated using Cox regression and based on an "intent-to-treat" (ITT) analysis wherein patients were classified based on dialytic modality received on follow-up day 90. RESULTS: Adjusted mortality rates were significantly decreased on CAPD/CCPD relative to HD [RR = 0.73, 95% confidence interval (CI) = (0.69, 0.77)] based on the AT analysis. Most of the protective effect of CAPD/CCPD was concentrated in the first 2 years of follow-up post-RRT initiation. Based on the ITT analysis, the estimated CAPD/ CCPD effect was greatly reduced, with HR = 0.93 (0.87, 0.99). CONCLUSIONS: We provide further evidence that CAPD/CCPD is not an inferior dialytic modality to HD, particularly in the short term. Comparing mortality rates on CAPD/CCPD and HD is inherently difficult due to the potential for bias. Discrepancies between our results and those of previous investigations, and variability in findings among previous studies, relate to differences in clinical and demographic setting, patient populations, study design, statistical methods, and interaction between the dialytic modality effect and various other covariables.

Canada↗